Rolando Rengifo advises clients on patent prosecution, portfolio strategy, freedom-to-operate analyses, diligence, and related IP counseling, with a focus on life sciences, biotechnology, pharmaceutical, and chemical technologies. He helps clients protect and evaluate innovations involving small molecules, biologics, protein chemistry, immunology, diagnostics, and related technologies.
Rolando has experience preparing and prosecuting U.S. and international patent applications, responding to Office Actions, conducting examiner interviews, and coordinating foreign prosecution strategy. He advises on patentability, validity, infringement, and freedom-to-operate issues, including in connection with diligence, licensing, pre-litigation assessment, and portfolio development.
Rolando has contributed to commentary on a range of patent law and policy developments affecting patent prosecution, enforcement, and innovation in the life sciences.